| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,647 |
10,066 |
$1.71M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
6,297 |
5,802 |
$1.38M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,852 |
2,678 |
$948K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,927 |
2,703 |
$316K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,284 |
2,220 |
$229K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,821 |
4,368 |
$207K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,988 |
1,882 |
$134K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,383 |
2,143 |
$89K |
| 71046 |
Radiologic examination, chest; 2 views |
2,053 |
2,000 |
$87K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,205 |
676 |
$58K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
578 |
575 |
$50K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,300 |
1,163 |
$41K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
464 |
398 |
$40K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
229 |
219 |
$39K |
| 71045 |
Radiologic examination, chest; single view |
753 |
727 |
$36K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
556 |
550 |
$34K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,128 |
1,052 |
$33K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
200 |
196 |
$28K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,320 |
444 |
$28K |
| 70450 |
Computed tomography, head or brain; without contrast material |
269 |
259 |
$25K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
574 |
571 |
$23K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
837 |
297 |
$23K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,614 |
3,504 |
$19K |
| 80061 |
Lipid panel |
3,043 |
3,021 |
$19K |
| 80053 |
Comprehensive metabolic panel |
8,662 |
7,896 |
$18K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
415 |
410 |
$17K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,455 |
1,443 |
$17K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,143 |
8,246 |
$15K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
163 |
163 |
$11K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
385 |
361 |
$10K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,186 |
2,156 |
$9K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,422 |
2,250 |
$7K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
102 |
100 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,130 |
3,821 |
$7K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
68 |
68 |
$5K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,291 |
1,203 |
$5K |
| 84439 |
|
1,263 |
1,250 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
12,848 |
11,274 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,880 |
1,737 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
347 |
337 |
$4K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
107 |
55 |
$3K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
28 |
27 |
$3K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
151 |
151 |
$2K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,262 |
1,198 |
$2K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
23 |
23 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
189 |
181 |
$2K |
| 83735 |
|
1,669 |
1,452 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
149 |
148 |
$2K |
| 82607 |
|
272 |
270 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
59 |
58 |
$2K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
564 |
552 |
$2K |
| 85027 |
|
1,156 |
1,089 |
$2K |
| 73130 |
|
131 |
129 |
$1K |
| 85610 |
|
1,950 |
1,660 |
$1K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
13 |
13 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
392 |
356 |
$971.41 |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
12 |
12 |
$932.78 |
| 97161 |
|
13 |
13 |
$909.19 |
| 99441 |
|
103 |
97 |
$755.27 |
| 73630 |
|
85 |
85 |
$688.79 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
909 |
814 |
$581.21 |
| 87070 |
|
579 |
570 |
$567.93 |
| 99442 |
|
38 |
34 |
$550.45 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
77 |
75 |
$549.49 |
| 73610 |
|
59 |
59 |
$463.32 |
| 81025 |
|
2,185 |
2,050 |
$446.16 |
| 81001 |
|
3,046 |
2,848 |
$431.74 |
| 87077 |
|
171 |
165 |
$360.41 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
376 |
350 |
$342.48 |
| 81002 |
|
168 |
164 |
$339.09 |
| 83690 |
|
2,123 |
1,949 |
$310.91 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,578 |
3,329 |
$306.33 |
| 87186 |
|
92 |
90 |
$296.23 |
| 81003 |
|
1,686 |
1,615 |
$286.39 |
| 73564 |
|
12 |
12 |
$280.41 |
| 73030 |
|
12 |
12 |
$261.36 |
| 90686 |
|
16 |
16 |
$241.69 |
| 85730 |
|
855 |
810 |
$226.43 |
| 80076 |
|
54 |
52 |
$218.94 |
| 84484 |
|
1,200 |
1,054 |
$200.03 |
| 85007 |
|
265 |
245 |
$152.51 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
12 |
12 |
$152.24 |
| 82150 |
|
802 |
752 |
$135.04 |
| 83540 |
|
40 |
39 |
$110.14 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
13 |
13 |
$99.19 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
13 |
$99.19 |
| 84481 |
|
13 |
13 |
$82.49 |
| 87807 |
|
39 |
39 |
$56.03 |
| 82043 |
|
12 |
12 |
$46.14 |
| 86140 |
|
28 |
26 |
$45.39 |
| 83605 |
|
2,302 |
2,108 |
$41.47 |
| 82728 |
|
12 |
12 |
$38.23 |
| 90715 |
|
12 |
12 |
$35.65 |
| 84100 |
|
64 |
56 |
$30.28 |
| 82248 |
|
13 |
12 |
$20.32 |
| 85379 |
|
25 |
25 |
$6.44 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
57 |
55 |
$6.00 |
| 74022 |
|
12 |
12 |
$4.55 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,758 |
1,606 |
$1.03 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
261 |
225 |
$0.90 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
672 |
562 |
$0.44 |
| J2060 |
Injection, lorazepam, 2 mg |
93 |
86 |
$0.00 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
176 |
176 |
$0.00 |
| J3490 |
Unclassified drugs |
795 |
712 |
$0.00 |
| 87430 |
|
358 |
350 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
61 |
51 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
49 |
47 |
$0.00 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
124 |
121 |
$0.00 |
| 87040 |
|
15 |
15 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
355 |
301 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
731 |
706 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
17 |
15 |
$0.00 |